Cargando…

Mild Respiratory COVID-Induced Neuroinflammation Causes Neurological Deficits

Detalles Bibliográficos
Autores principales:	Yang, Junlin, Qiu, Mengsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734999/ https://www.ncbi.nlm.nih.gov/pubmed/36471132 http://dx.doi.org/10.1007/s12264-022-00990-y

Ejemplares similares

Single-cell transcriptomics reveals neuroinflammation in severe COVID-19
por: Lemprière, Sarah
Publicado: (2021)

New insights into the neurological effects of COVID-19
por: Wood, Heather
Publicado: (2020)

Saliva biomarkers in neurological disorders: A “spitting image” of brain health?
por: Walton, Emma Louise
Publicado: (2018)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

Safety and efficacy of COVID-19 vaccines in people with neurological disorders
por: Wood, Heather
Publicado: (2021)

Cyro-EM structure of human mGlus: leading therapeutic potential to neurological diseases
por: Xiao, Huan, et al.
Publicado: (2021)

Inflammation links mild COVID-19 with long-term cognitive impairment
por: Lemprière, Sarah
Publicado: (2022)

Cell perturbation in choroid plexus and cortex aiding COVID-19 neurological symptoms
por: Mao, Xiao-Yuan, et al.
Publicado: (2021)

Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin
por: Srodulski, Sarah, et al.
Publicado: (2014)

Resveratrol attenuates neurological deficit and neuroinflammation following intracerebral hemorrhage
por: Cai, Jia-Chen, et al.
Publicado: (2018)

Pharmacotherapy for mild hypertension
por: Diao, Diana, et al.
Publicado: (2013)

We refuse to die – T cells causing havoc
por: Kattner, Aila Akosua
Publicado: (2021)

Beyond the bowel – chaos caused by leaky barriers
por: Kattner, Aila Akosua
Publicado: (2023)

EAN VIRTUAL 2020 — THE LARGEST NEUROLOGY CONFERENCE IN HISTORY
por: Fyfe, Ian
Publicado: (2020)

COVID-19 and Tuberculosis
por: Yang, Heng, et al.
Publicado: (2020)

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021)

Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats
por: Liew, Hock-Kean, et al.
Publicado: (2012)

The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis
por: Yang, Jing, et al.
Publicado: (2020)

Restored oligodendrogenesis by fibroblast growth factor 17: molecular mechanism for rejuvenating ageing-related memory deficit
por: Xiong, Xiao-Yi, et al.
Publicado: (2022)

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
por: Lepeta, Katarzyna, et al.
Publicado: (2016)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
por: Yang, Jing, et al.
Publicado: (2020)

Neuroinflammation in mild respiratory COVID-19: insights into cognitive impairment in milder cases
por: Li, Qian, et al.
Publicado: (2022)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

Don't sugar coat the COVID (only the vasculature)
por: Häfner, Sophia Julia
Publicado: (2020)

Dental Pulp Stem Cell-Derived Factors Alleviate Subarachnoid Hemorrhage-Induced Neuroinflammation and Ischemic Neurological Deficits
por: Chen, Te-Fu, et al.
Publicado: (2019)

Pandemic number five – Latest insights into the COVID-19 crisis
por: Häfner, Sophia Julia
Publicado: (2020)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

The Application of Corticosteroids in COVID-19: A Two-edged Sword
por: Li, Na, et al.
Publicado: (2020)

What we have learned from COVID-19 pandemic?
por: Chen, Hsiu-Hsi, et al.
Publicado: (2021)

Structural basis of signaling of cannabinoids receptors: paving a way for rational drug design in controling mutiple neurological and immune diseases
por: Huang, Shenming, et al.
Publicado: (2020)

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020)

Recognition of Salmonella by Dectin-1 induces presentation of peptide antigen to type B T cells
por: Jackson, Nicola, et al.
Publicado: (2014)

A next‐generation vaccine for broader and long‐lasting COVID‐19 protection
por: Xi, Jinxiang, et al.
Publicado: (2022)

Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
por: Cesta, Maria Candida, et al.
Publicado: (2022)

Germacrone alleviates neurological deficits following traumatic brain injury by modulating neuroinflammation and oxidative stress
por: Zhuang, Sujing, et al.
Publicado: (2021)

Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage
por: Zi, Liu, et al.
Publicado: (2021)

European Respiratory Society International Congress 2018: Allied Respiratory Professionals’ report of highlighted sessions
por: Rutter, Matthew, et al.
Publicado: (2019)

Potential mechanisms by which impaired ketogenesis links metabolism to T‐cell dysfunction in patients with severe COVID‐19
por: Wang, Bin, et al.
Publicado: (2022)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m42v3rcalrn4u6li04cjjtcism